Valuation: Amgen Inc.

Market Cap 226B 1,126B 202B 188B 171B 322B 21,580B 324B 2,264B 886B 11,136B 848B 829B 35,836B P/E 2026 *
26.5x
P/E 2027 * 23.7x
Enterprise Value 267B 1,333B 239B 223B 202B 382B 25,552B 384B 2,681B 1,049B 13,186B 1,004B 982B 42,432B EV / Sales 2026 *
6.86x
EV / Sales 2027 * 6.48x
Free-Float
99.77%
Yield 2026 *
2.42%
Yield 2027 * 2.55%
1 day-0.71%
1 week+3.15%
Current month-5.06%
1 month+7.33%
3 months+12.22%
6 months+18.23%
Current year+12.60%
1 week 71.54
Extreme 71.54
74.8
1 month 68.98
Extreme 68.98
80.47
Current year 48.4
Extreme 48.4
83.38
1 year 48.4
Extreme 48.4
83.38
3 years 45.12
Extreme 45.12
83.38
5 years 37.52
Extreme 37.52
83.38
10 years 15.78
Extreme 15.780356
83.38
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+3.15% - - 224B
+0.28%+3.46%+41.89%+93.71% 1,051B
+0.88%+4.27%+38.28%+68.70% 630B
+1.68%+5.78%+21.96%+89.56% 489B
-0.10%+4.24%+69.15%+40.41% 359B
+0.61%+3.18%+24.05%+42.46% 344B
+0.72%+2.99%+14.29%+34.71% 272B
+0.23%+2.23%-5.91%+8.15% 246B
+0.65%+3.62%+43.93%+46.50% 224B
-0.49%+4.01%+28.38%+95.97% 187B
Average +0.32%+3.11%+30.67%+57.80% 422.63B
Weighted average by Cap. +0.35%+3.18%+34.07%+66.93%

Financials

2026 *2027 *
Net sales 38.97B 194B 34.88B 32.52B 29.5B 55.63B 3,725B 55.98B 391B 153B 1,922B 146B 143B 6,186B 40.37B 201B 36.14B 33.69B 30.56B 57.64B 3,859B 58B 405B 158B 1,991B 152B 148B 6,409B
Net income 8.53B 42.54B 7.64B 7.12B 6.46B 12.18B 815B 12.26B 85.56B 33.49B 421B 32.05B 31.34B 1,354B 9.39B 46.82B 8.41B 7.84B 7.11B 13.41B 898B 13.49B 94.17B 36.86B 463B 35.27B 34.49B 1,491B
Net Debt 41.55B 207B 37.2B 34.68B 31.45B 59.32B 3,972B 59.69B 417B 163B 2,050B 156B 153B 6,596B 35.9B 179B 32.14B 29.96B 27.17B 51.25B 3,432B 51.57B 360B 141B 1,771B 135B 132B 5,698B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
09/10/26 R$74.27 -0.71% 74
08/10/26 R$74.80 +0.92% 1,089
07/10/26 R$74.12 +3.30% 63
06/10/26 R$71.75 -0.35% 200
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
417.57USD
Average target price
393.91USD
Spread / Average Target
-5.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.